Cargando…
PB2132: EXCALIBER-RRMM: A PHASE 3, TWO-STAGE STUDY OF IBERDOMIDE, DARATUMUMAB, AND DEXAMETHASONE VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429394/ http://dx.doi.org/10.1097/01.HS9.0000975292.31324.26 |
| _version_ | 1785090701900382208 |
|---|---|
| author | Lonial, Sagar Quach, Hang Dimopoulos, Meletios A. Rodríguez-Otero, Paula Berdeja, Jesus Richardson, Paul Kyada, Margee Chu, Shuyu Chen, Min Abad, Patricia Morando, Juliane van de Donk, Niels W.C.J. |
| author_facet | Lonial, Sagar Quach, Hang Dimopoulos, Meletios A. Rodríguez-Otero, Paula Berdeja, Jesus Richardson, Paul Kyada, Margee Chu, Shuyu Chen, Min Abad, Patricia Morando, Juliane van de Donk, Niels W.C.J. |
| author_sort | Lonial, Sagar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429394 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104293942023-08-17 PB2132: EXCALIBER-RRMM: A PHASE 3, TWO-STAGE STUDY OF IBERDOMIDE, DARATUMUMAB, AND DEXAMETHASONE VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA Lonial, Sagar Quach, Hang Dimopoulos, Meletios A. Rodríguez-Otero, Paula Berdeja, Jesus Richardson, Paul Kyada, Margee Chu, Shuyu Chen, Min Abad, Patricia Morando, Juliane van de Donk, Niels W.C.J. Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429394/ http://dx.doi.org/10.1097/01.HS9.0000975292.31324.26 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Lonial, Sagar Quach, Hang Dimopoulos, Meletios A. Rodríguez-Otero, Paula Berdeja, Jesus Richardson, Paul Kyada, Margee Chu, Shuyu Chen, Min Abad, Patricia Morando, Juliane van de Donk, Niels W.C.J. PB2132: EXCALIBER-RRMM: A PHASE 3, TWO-STAGE STUDY OF IBERDOMIDE, DARATUMUMAB, AND DEXAMETHASONE VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title | PB2132: EXCALIBER-RRMM: A PHASE 3, TWO-STAGE STUDY OF IBERDOMIDE, DARATUMUMAB, AND DEXAMETHASONE VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_full | PB2132: EXCALIBER-RRMM: A PHASE 3, TWO-STAGE STUDY OF IBERDOMIDE, DARATUMUMAB, AND DEXAMETHASONE VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_fullStr | PB2132: EXCALIBER-RRMM: A PHASE 3, TWO-STAGE STUDY OF IBERDOMIDE, DARATUMUMAB, AND DEXAMETHASONE VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_full_unstemmed | PB2132: EXCALIBER-RRMM: A PHASE 3, TWO-STAGE STUDY OF IBERDOMIDE, DARATUMUMAB, AND DEXAMETHASONE VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_short | PB2132: EXCALIBER-RRMM: A PHASE 3, TWO-STAGE STUDY OF IBERDOMIDE, DARATUMUMAB, AND DEXAMETHASONE VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_sort | pb2132: excaliber-rrmm: a phase 3, two-stage study of iberdomide, daratumumab, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed/refractory multiple myeloma |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429394/ http://dx.doi.org/10.1097/01.HS9.0000975292.31324.26 |
| work_keys_str_mv | AT lonialsagar pb2132excaliberrrmmaphase3twostagestudyofiberdomidedaratumumabanddexamethasoneversusdaratumumabbortezomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma AT quachhang pb2132excaliberrrmmaphase3twostagestudyofiberdomidedaratumumabanddexamethasoneversusdaratumumabbortezomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma AT dimopoulosmeletiosa pb2132excaliberrrmmaphase3twostagestudyofiberdomidedaratumumabanddexamethasoneversusdaratumumabbortezomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma AT rodriguezoteropaula pb2132excaliberrrmmaphase3twostagestudyofiberdomidedaratumumabanddexamethasoneversusdaratumumabbortezomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma AT berdejajesus pb2132excaliberrrmmaphase3twostagestudyofiberdomidedaratumumabanddexamethasoneversusdaratumumabbortezomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma AT richardsonpaul pb2132excaliberrrmmaphase3twostagestudyofiberdomidedaratumumabanddexamethasoneversusdaratumumabbortezomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma AT kyadamargee pb2132excaliberrrmmaphase3twostagestudyofiberdomidedaratumumabanddexamethasoneversusdaratumumabbortezomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma AT chushuyu pb2132excaliberrrmmaphase3twostagestudyofiberdomidedaratumumabanddexamethasoneversusdaratumumabbortezomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma AT chenmin pb2132excaliberrrmmaphase3twostagestudyofiberdomidedaratumumabanddexamethasoneversusdaratumumabbortezomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma AT abadpatricia pb2132excaliberrrmmaphase3twostagestudyofiberdomidedaratumumabanddexamethasoneversusdaratumumabbortezomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma AT morandojuliane pb2132excaliberrrmmaphase3twostagestudyofiberdomidedaratumumabanddexamethasoneversusdaratumumabbortezomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma AT vandedonknielswcj pb2132excaliberrrmmaphase3twostagestudyofiberdomidedaratumumabanddexamethasoneversusdaratumumabbortezomibanddexamethasoneinpatientswithrelapsedrefractorymultiplemyeloma |